2022
DOI: 10.3390/ijms23168962
|View full text |Cite
|
Sign up to set email alerts
|

(-)-Epicatechin Is a Biased Ligand of Apelin Receptor

Andrés Portilla-Martínez,
Miguel Ángel Ortiz-Flores,
Eduardo Meaney
et al.

Abstract: (-)-Epicatechin (EC) is part of a large family of biomolecules called flavonoids and is widely distributed in the plant kingdom. Several studies have shown the beneficial effects of EC consumption. Many of these reported effects are exerted by activating the signaling pathways associated with the activation of two specific receptors: the G protein-coupled estrogen receptor (GPER), a transmembrane receptor, and the pregnane X receptor (PXR), which is a nuclear receptor. However, the effects of EC are so diverse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…Therefore, it is crucial to design APJ receptor biased agonists in order to stimulate the APJ-mediated signaling pathways selectively: G protein-dependent versus β-arrestin recruitment-dependent. Research on APJ receptor biased agonists is under intense investigation currently [17][18][19][20]. To examine this hypothesis, our research group is currently designing and evaluating the efficacy of novel APJ receptor biased agonists [18].…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, it is crucial to design APJ receptor biased agonists in order to stimulate the APJ-mediated signaling pathways selectively: G protein-dependent versus β-arrestin recruitment-dependent. Research on APJ receptor biased agonists is under intense investigation currently [17][18][19][20]. To examine this hypothesis, our research group is currently designing and evaluating the efficacy of novel APJ receptor biased agonists [18].…”
Section: Discussionmentioning
confidence: 99%